Stella Chemifa Corporation logo

Stella Chemifa Corporation (SLO)

Market Open
7 Aug, 20:00
XFRA XFRA
28. 40
+0.2
+0.7092%
466.27M Market Cap
- P/E Ratio
1.19% Div Yield
10 Volume
- Eps
28.2
Previous Close
Add Transaction
Day Range
28.4 28.4
Year Range
21.4 43.4
Want to track SLO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SLO trading today higher at €28.4, an increase of 0.7092% from yesterday's close, completing a monthly decrease of -19.3182% or -€6.8. Over the past 12 months, SLO stock gained 19.3277%.
SLO pays dividends to its shareholders, with the most recent payment made on Dec 01, 2025. The next announced payment will be in In 1 month on Sep 29, 2026 for a total of €90.
The last earnings report, released on Aug 05, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 4 different exchanges and in various currencies, with the primary listing on JPX (JPY).

SLO Chart

People also search for

P22
Nagase & Co., Ltd.
6.7
0%
1U3
Bic Camera Inc.
9.15
-0.5435%
3S5
Red Star Macalline Group Corporation Ltd.
0.12
0%
Fufeng Group Ltd.
0.55
-0.9009%
31S
Stella International Holdings Ltd.
1.54
-0.6452%

Stella Chemifa Corporation (SLO) FAQ

What is the stock price today?

The current price is €28.40.

On which exchange is it traded?

Stella Chemifa Corporation is listed on XFRA.

What is its stock symbol?

The ticker symbol is SLO.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 1.19%.

What is its market cap?

As of today, the market cap is 466.27M.

Has Stella Chemifa Corporation ever had a stock split?

No, there has never been a stock split.

Stella Chemifa Corporation Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Aki Hashimoto CEO
XFRA Exchange
JP3399720006 ISIN
US Country
694 Employees
29 Sep 2026 Last Dividend
- Last Split
- IPO Date

Overview

Stella Chemifa Corporation, originally known as Hashimoto Chemical Corporation before its name change in 1997, is a longstanding entity established in 1916. Positioned in Osaka, Japan, the company operates on a global scale, specializing in the manufacturing and selling of inorganic fluorine compounds. Its significant role in the chemical industry is highlighted by its extensive product range, catering to various sectors, including semiconductors, liquid crystals, optical materials, batteries, and even the field of nuclear energy and medical treatments. Moreover, Stella Chemifa extends its expertise to the transportation of special chemical substances, high-pressure gas, hazardous materials, and related products, showcasing a comprehensive involvement in the chemical sector. Notably, the company is actively engaged in the development of innovative treatments, such as Boron Neutron Capture therapy, contributing to cancer treatment advancements.

Products and Services

  • Hydrofluoric Acid and Derivatives: The company produces hydrofluoric acid, buffered hydrofluoric acid, and etching solutions, primarily used in the manufacturing of semiconductors and liquid crystal products.
  • Fluorides for Optical Materials: Stella Chemifa offers a variety of fluorides including calcium, aluminum, lithium, strontium, barium, magnesium, and lead fluoride which are utilized in the production of optical materials.
  • Lithium Hexafluorophosphate for Batteries: This compound is specifically catered for use in battery applications, underlining the company's contribution to the energy sector.
  • Reactive Catalysts: A range of boron trifluoride complexes such as boron trifluoride diethyl ether, boron trifluoride dimethyl ether, among others, are offered for use as reactive catalysts in various chemical processes.
  • Surface Treatment and CFC Alternatives: Products like anhydrous hydrofluoric acid and 55% hydrofluoric acid are provided for applications in surface treatment and as alternatives for chlorofluorocarbons (CFCs).
  • Nuclear Energy Applications: The company supplies potassium fluoroborate and boric acid, substances integral to nuclear energy applications.
  • GMP-Compliant Products: Stella Chemifa manufactures tin fluoride (II) USP, adhering to Good Manufacturing Practice (GMP) standards, highlighting its capability to meet rigorous quality criteria.
  • Additional Chemical Products: A wide assortment including fluorosilicic acid, various fluoroborates, and fluorides, demonstrates the company’s extensive chemical manufacturing capabilities.
  • Specialized Transport Services: Beyond just manufacturing, Stella Chemifa offers transportation services for special chemical substances, high-pressure gas, hazardous materials, ensuring the safe and secure handling of chemicals.
  • Cancer Treatment Development: Actively involved in medical research, the company is developing Boron Neutron Capture therapy, a promising cancer treatment, showcasing its commitment to healthcare advancements.

Contact Information

Address: Meiji Yasuda Seimei Osaka Midosuji Bldg, Osaka, Japan, 541-0044
Phone: 81 6 4707 1511